Australia, 25th Apr 2024 – Neuralia TMS, a pioneering medical facility based in Palmyra, is pleased to introduce an innovative depression treatment solution to the Perth community, neuraliatms.com.au/depression/treatment/perth/. Specialising in transcranial magnetic stimulation (TMS) therapy, Neuralia TMS offers a groundbreaking approach for patients suffering from treatment-resistant depression.
This advanced therapy represents a significant development in mental health treatments, providing new hope for individuals seeking effective solutions without the drawbacks of traditional methods. Transcranial magnetic stimulation (TMS) is a non-invasive procedure that utilises magnetic fields to stimulate nerve cells in the brain involved in mood control and depression. TMS therapy is particularly designed for patients who have not responded to standard depression treatments such as antidepressants and psychotherapy.
Dr. Shanek Wick, Director of Neuralia TMS, highlights the benefits of this therapy, “At Neuralia TMS, the team is committed to advancing mental health treatment options. TMS therapy is a testament to dedication; it’s a non-invasive, outpatient treatment that requires no surgery or medication. The patients often begin to experience significant relief from depressive symptoms within just a few weeks of starting treatment.”
The procedure is painless and conducted in a comfortable outpatient setting. During a TMS session, a magnetic coil is placed against the scalp near the forehead. The device delivers a magnetic pulse that stimulates brain cells associated with mood regulation. Each treatment session typically lasts between 30 and 60 minutes, and patients can return to their daily activities immediately afterwards without any downtime.
TMS therapy has been approved by numerous global health authorities, including the FDA in the United States and the Therapeutic Goods Administration (TGA) in Australia. It has been shown to be safe and generally well-tolerated, with few side effects compared to those often associated with antidepressant medications.
Dr. Wick also discussed the future of depression treatment at Neuralia TMS, “Looking forward, the team is focused on not only providing state-of-the-art treatment but also on expanding the services to reach more individuals struggling with mental health conditions.
Depression is a complex disease, and it demands innovative approaches like TMS. The goal is to continue to lead in this area, providing cutting-edge treatments that set new standards in effectiveness and patient care.”
Neuralia TMS is now accepting patients for TMS therapy at their Palmyra clinic. Those interested in exploring this treatment option are encouraged to contact the clinic to learn more about how TMS might help them achieve better mental health outcomes.
For more information regarding depression treatment Perth services, reach out to Neuralia TMS at 08 6230 3996 or via email at info@neuralia.com.au.
Media Contact
Organization: Neuralia TMS Perth (Palmyra)
Contact Person: Dr Shanek Wick
Website: https://www.neuraliatms.com.au/
Email: Send Email
Contact Number: +61862303996
Address: 7/25 Foss St
Address 2: Palmyra WA 6157
Country: Australia
Release Id: 25042411348
The post Neuralia TMS Announces Depression Treatment Solutions in Perth appeared first on King NewsWire. It is provided by a third-party content provider. King Newswire makes no warranties or representations in connection with it.
